arrow
E

Erica K. Sloan

monash university
H指数:47
被引数:9,985

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Discovery of APO-50815, a Potent WEE1 Kinase Inhibitor with Exceptional Efficacy against Patient-Derived Colorectal Cancer Organoids

APO-50815的发现,一种具有对源自患者的结直肠癌类器官显著疗效的强效WEE1激酶抑制剂

2026-04-050
PRE
Aprepitant use during chemotherapy and association with survival in women with early breast cancer

Botteri, E.; Hjorth, S.; Conforti, F.; Bagnardi, V.; Andreassen, B.K.; Stoer, N.C.; Bhargava, S.; Ursin, G.; Gandini, S.; Sloan, E.K.; 等. 化疗期间阿瑞匹坦的使用及其与早期乳腺癌女性患者生存期的关联. J. Natl. Cancer Inst. 2025, djaf178. [Google Scholar] [CrossRef] [PubMed]

2025-08-013
OAAI
Decorin, an exercise-induced secretory protein, is associated with improved prognosis in breast cancer patients but does not mediate anti-tumorigenic tissue crosstalk in mice

Decorin,一种运动诱导的分泌蛋白,与乳腺癌患者预后改善相关,但在小鼠中不介导抗肿瘤组织间串扰。

2025-02-281
OAAI
Gerotherapeutics: aging mechanism-based pharmaceutical and behavioral interventions to reduce cancer racial and ethnic disparities

老年治疗学: 基于衰老机制的药物和行为干预,以减少癌症种族和民族差异

2024-08-280
PRE
Next Directions in the Neuroscience of Cancers Arising outside the CNS
2024-04-044
OA
Beta-blockade enhances anthracycline control of metastasis in triple-negative breast cancer

Β-阻断增强三阴性乳腺癌中蒽环类药物对转移的控制

2023-04-2633
PRE